BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Apotex Fermentation Inc. Resumes Shipping To The U.S.


5/10/2011 10:10:17 AM

- FDA's decision to lift import alert paves the way for Apotex's oral solid dose products to be available again for US consumers; Company moves forward to restore pipeline of shipments to the local market -

TORONTO, May 10 /PRNewswire/ - Apotex, one of the largest generic pharmaceutical manufacturers in the world, announced it will soon resume shipments of its oral solid dose products to the U.S. market. The announcement comes on the heels of a Food and Drug Administration (FDA) decision to lift its import alert at Apotex's largest solid dose manufacturing facility supplying product to the US.

"Apotex is pleased the FDA has recognized the enhancements to our global quality systems," stated Dr Jeremy B. Desai, Apotex' Chief Operating Officer.

Apotex will immediately resume manufacturing and shipping of our solid dose products into the US market.

About Apotex
Apotex Inc., with 6000 employees in Canada sells to 115 countries a portfolio of approximately 300 affordable medicines around the globe and is the largest generic company in the country. It is the top research and development Canadian corporation in the pharmaceutical industry with planned expenditures of $2 billion over the next ten years.

Apotex Corp. is the US Company that markets the products of Apotex, Inc. Through its sales and marketing headquarters in Weston, Florida and operations center in Indianapolis, Apotex Corp. is committed to providing safe and affordable generic medicines.

www.apotex.com

SOURCE Apotex Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES